SZELA MARY T (CEO and President) purchased 2.3% of their position (10.04K shares) of TRISALUS LIFE SCIENCES, INC. on the open market
Open‑market purchase worth $51.8K — a small addition. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 1/31/2025ACC: 0001415889-25-002536
DirectorOfficer· CEO and President
Since Feb 2026
+10.04K
Net shares
Net buyer
$51.8K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
10.04K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+5.03K
Price / share
$5.03
Trade value
$25.30K
% of position
1.2%
1/29/2025
434.22K→439.25K
Common Stock
Direct
Shares
+5.01K
Price / share
$5.28
Trade value
$26.45K
% of position
1.1%
1/30/2025
439.25K→444.26K
Total
Net shares
+10.04K
Net value
$51.75K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/29/2025 | P · Purchase | +5.03K | $5.03 | $25.30K | 1.2% | 434.22K | 439.25K |
| Common Stock Direct | 1/30/2025 | P · Purchase | +5.01K | $5.28 | $26.45K | 1.1% | 439.25K | 444.26K |
| Total | +10.04K | $51.75K | ||||||
Derivative Transactions0
No derivative transactions reported